124 related articles for article (PubMed ID: 38336522)
1. Impact of nonalcoholic fatty liver disease on the risk of gallbladder polyps in lean and non-obese individuals: A cohort study.
Kim NH; Kang JH; Kim HJ
Hepatobiliary Pancreat Dis Int; 2024 Jan; ():. PubMed ID: 38336522
[TBL] [Abstract][Full Text] [Related]
2. Association between nonalcoholic fatty liver disease and gallstone risk in nonobese and lean individuals.
Kim NH; Kang JH; Kim HJ
Eur J Gastroenterol Hepatol; 2024 Jul; 36(7):945-951. PubMed ID: 38652507
[TBL] [Abstract][Full Text] [Related]
3. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
[TBL] [Abstract][Full Text] [Related]
4. Association between the lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes in a healthy population of Northwest China: a retrospective cohort study with a 2-year follow-up period.
Li N; Xang W; Wu S; Li D; Chang M; Xie C; Zhang MY; Tan H
Front Endocrinol (Lausanne); 2023; 14():1173757. PubMed ID: 37435491
[TBL] [Abstract][Full Text] [Related]
5. The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan.
Lin CL; Tai CM; Huang JF; Liu CJ; Chen HF; Cheng PN; Chen CY; Peng CY; Wang CC; Weng SH; Tseng TC; Kao JH
J Gastroenterol Hepatol; 2022 Oct; 37(10):1901-1910. PubMed ID: 35790343
[TBL] [Abstract][Full Text] [Related]
6. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
[TBL] [Abstract][Full Text] [Related]
7. Non-obese or lean non-alcoholic fatty liver disease was associated with increased risk of cancer in patients with type 2 diabetes mellitus.
Chen N; Zhou J; Wang K; Li X; Li Z
BMJ Open Diabetes Res Care; 2023 Feb; 11(1):. PubMed ID: 36792168
[TBL] [Abstract][Full Text] [Related]
8. Sex-specific Cutoff Values of Visceral Fat Area for Lean vs. Overweight/Obese Nonalcoholic Fatty Liver Disease in Asians.
Lee S; Kim KW; Lee J
J Clin Transl Hepatol; 2022 Aug; 10(4):595-599. PubMed ID: 36062272
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic Fatty Liver Disease in Lean Subjects: Associations With Metabolic Dysregulation and Cardiovascular Risk-A Single-Center Cross-Sectional Study.
Semmler G; Wernly S; Bachmayer S; Wernly B; Schwenoha L; Huber-Schönauer U; Stickel F; Niederseer D; Aigner E; Datz C
Clin Transl Gastroenterol; 2021 Apr; 12(4):e00326. PubMed ID: 33821832
[TBL] [Abstract][Full Text] [Related]
10. Weight change and resolution of fatty liver in normal weight individuals with nonalcoholic fatty liver disease.
Sinn DH; Kang D; Cho SJ; Paik SW; Guallar E; Cho J; Gwak GY
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e529-e534. PubMed ID: 33867441
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management.
Chrysavgis L; Ztriva E; Protopapas A; Tziomalos K; Cholongitas E
World J Gastroenterol; 2020 Nov; 26(42):6514-6528. PubMed ID: 33268944
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease.
Zeng J; Yang RX; Sun C; Pan Q; Zhang RN; Chen GY; Hu Y; Fan JG
World J Gastroenterol; 2020 Apr; 26(15):1792-1804. PubMed ID: 32351294
[TBL] [Abstract][Full Text] [Related]
13. Familial clustering of nonalcoholic fatty liver disease in first-degree relatives of adults with lean nonalcoholic fatty liver disease.
Niltwat S; Limwongse C; Charatcharoenwitthaya N; Bunditvorapoom D; Bandidniyamanon W; Charatcharoenwitthaya P
Liver Int; 2023 Dec; 43(12):2713-2726. PubMed ID: 37804066
[TBL] [Abstract][Full Text] [Related]
14. Hepatic fat, not visceral fat, is associated with gallbladder polyps: a study of 2643 healthy subjects.
Lim SH; Kim D; Kang JH; Song JH; Yang SY; Yim JY; Chung SJ; Kim JS; Cho SH
J Gastroenterol Hepatol; 2015 Apr; 30(4):767-74. PubMed ID: 25376159
[TBL] [Abstract][Full Text] [Related]
15. Systematic review with meta-analysis: the significance of histological disease severity in lean patients with nonalcoholic fatty liver disease.
Sookoian S; Pirola CJ
Aliment Pharmacol Ther; 2018 Jan; 47(1):16-25. PubMed ID: 29083036
[TBL] [Abstract][Full Text] [Related]
16. Clinical Characteristics and Metabolic Profiles of Non-Alcoholic Fatty Liver Disease (NAFLD) in Lean Patients and Their Comparison with Obese and Overweight NAFLD.
Chakrabarty M; Jha AN; Sharma DJ
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443531
[TBL] [Abstract][Full Text] [Related]
17. Lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes mellitus: A literature review and meta-analysis.
Gao Y; Zhao T; Song S; Duo Y; Gao J; Yuan T; Zhao W
Diabetes Res Clin Pract; 2023 Jun; 200():110699. PubMed ID: 37169306
[TBL] [Abstract][Full Text] [Related]
18. Adiponectin-leptin ratio for the early detection of lean non-alcoholic fatty liver disease independent of insulin resistance.
Lu CW; Yang KC; Chi YC; Wu TY; Chiang CH; Chang HH; Huang KC; Yang WS
Ann Med; 2023 Dec; 55(1):634-642. PubMed ID: 36790383
[TBL] [Abstract][Full Text] [Related]
19. Natural History of Nonalcoholic Fatty Liver Disease With Normal Body Mass Index: A Population-Based Study.
Ahmed OT; Gidener T; Mara KC; Larson JJ; Therneau TM; Allen AM
Clin Gastroenterol Hepatol; 2022 Jun; 20(6):1374-1381.e6. PubMed ID: 34265444
[TBL] [Abstract][Full Text] [Related]
20. Low serum vitamin D concentrations are associated with obese but not lean NAFLD: a cross-sectional study.
Wang Q; Shi X; Wang J; Zhang J; Xu C
Nutr J; 2021 Apr; 20(1):30. PubMed ID: 33794916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
